A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Guselkumab at 52 weeks for the Treatment of Psoriatic Arthritis. J of Skin. 2024;8(1):s312. doi:10.25251/skin.8.supp.312